ALAN Asset Management
Beijingalanamc.com
Overview
ALAN Asset Management is a Beijing-based alternative asset management firm that focuses on equity investment, mezzanine and credit investment, real estate and infrastructure investment, and quantitative investment.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Taizhou Baiying Biotechnology | Sep 2022 | Series B | Co-investor |
| Shanghai Juncell Therapeutics Co., Ltd. | Jan 2022 | Series A Extension | Co-investor |
| Ankon Technologies | Sep 2020 | Early Funding | Co-investor |
| Shanghai Hanyu Medical Technology | Aug 2020 | Series D | Co-investor |
| HaiHe Biopharma | Jul 2020 | Series B | Co-investor |
Key People
Kexin Qu
Investment Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
